213 related articles for article (PubMed ID: 38353884)
1. Tacrolimus-Induced Neurotoxicity After Transplant: A Literature Review.
Verona P; Edwards J; Hubert K; Avorio F; Re VL; Di Stefano R; Carollo A; Johnson H; Provenzani A
Drug Saf; 2024 May; 47(5):419-438. PubMed ID: 38353884
[TBL] [Abstract][Full Text] [Related]
2. Delayed-Onset Psychosis Secondary to Tacrolimus Neurotoxicity After Lung Transplant: A Case Report and Systematic Review.
Gunther M; Jiang S; Banga A; Sher Y
J Acad Consult Liaison Psychiatry; 2023; 64(6):550-561. PubMed ID: 37778461
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation.
Wu Q; Marescaux C; Wolff V; Jeung MY; Kessler R; Lauer V; Chen Y
Eur Neurol; 2010; 64(3):169-77. PubMed ID: 20699617
[TBL] [Abstract][Full Text] [Related]
4. Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation.
Hayes D; Adler B; Turner TL; Mansour HM
Pediatr Neurol; 2014 Mar; 50(3):272-5. PubMed ID: 24405697
[TBL] [Abstract][Full Text] [Related]
5. Late fulminant posterior reversible encephalopathy syndrome after liver transplant.
Heidenhain C; Puhl G; Neuhaus P
Exp Clin Transplant; 2009 Sep; 7(3):180-3. PubMed ID: 19715529
[TBL] [Abstract][Full Text] [Related]
6. Catatonia as a manifestation of tacrolimus-induced neurotoxicity in organ transplant patients: a case series.
Chopra A; Das P; Rai A; Kuppuswamy PS; Li X; Huston J; Philbrick K; Sola C
Gen Hosp Psychiatry; 2012; 34(2):209.e9-11. PubMed ID: 21937118
[TBL] [Abstract][Full Text] [Related]
7. Donor Age Predicts Calcineurin Inhibitor Induced Neurotoxicity After Liver Transplantation.
Lué A; Martinez E; Navarro M; Laredo V; Lorente S; Jose Araiz J; Agustin Garcia-Gil F; Serrano MT
Transplantation; 2019 Aug; 103(8):e211-e215. PubMed ID: 30985573
[TBL] [Abstract][Full Text] [Related]
8. Posterior Reversible Encephalopathy Syndrome in Organ Transplantation.
Jeelani H; Sharma A; Halawa AM
Exp Clin Transplant; 2022 Jul; 20(7):642-648. PubMed ID: 35924741
[TBL] [Abstract][Full Text] [Related]
9. Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy.
Kapoor A; Birks E; Lenneman A; McCants K
Tex Heart Inst J; 2017 Jun; 44(3):205-208. PubMed ID: 28761402
[TBL] [Abstract][Full Text] [Related]
10. Overdose of Tacrolimus as the Trigger Causing Progression of Posterior Reversible Encephalopathy Syndrome and Subsequent Hepatic Infarction After Liver Transplant: A Case Report.
Tseng WC; Lai HC; Yeh CC; Fan HL; Wu ZF
Exp Clin Transplant; 2020 Feb; 18(1):128-132. PubMed ID: 30602365
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus-Induced Neurotoxicity in Early Post-Liver Transplant Saudi Patients: Incidence and Risk Factors.
Alissa DA; Alkortas D; Alsebayel M; Almasuood RA; Aburas W; Altamimi T; Devol EB; Al-Jedai AH
Ann Transplant; 2022 May; 27():e935938. PubMed ID: 35578566
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus for the prevention and treatment of rejection of solid organ transplants.
Scalea JR; Levi ST; Ally W; Brayman KL
Expert Rev Clin Immunol; 2016; 12(3):333-42. PubMed ID: 26588770
[TBL] [Abstract][Full Text] [Related]
13. Exploring the neuroregenerative potential of tacrolimus.
Saffari TM; Bedar M; Zuidam JM; Shin AY; Baan CC; Hesselink DA; Hundepool CA
Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1047-1057. PubMed ID: 31575290
[No Abstract] [Full Text] [Related]
14. Neurotoxicity of calcineurin inhibitors: impact and clinical management.
Bechstein WO
Transpl Int; 2000; 13(5):313-26. PubMed ID: 11052266
[TBL] [Abstract][Full Text] [Related]
15. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
[TBL] [Abstract][Full Text] [Related]
16. Neurologic Toxicities Associated with Tumor Necrosis Factor Inhibitors and Calcineurin Inhibitors.
Coe CL; Horst SN; Izzy MJ
Neurol Clin; 2020 Nov; 38(4):937-951. PubMed ID: 33040870
[TBL] [Abstract][Full Text] [Related]
17. Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation.
Barbas AS; Rege AS; Castleberry AW; Gommer J; Ellis MJ; Brennan TV; Collins BH; Martin AE; Ravindra KV; Vikraman DS; Sudan DL
Am J Transplant; 2013 Mar; 13(3):808-10. PubMed ID: 23331705
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review.
Song T; Rao Z; Tan Q; Qiu Y; Liu J; Huang Z; Wang X; Lin T
Medicine (Baltimore); 2016 Apr; 95(14):e3173. PubMed ID: 27057842
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
Plosker GL; Foster RH
Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity.
Bentata Y
Artif Organs; 2020 Feb; 44(2):140-152. PubMed ID: 31386765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
